Last updated: November 14, 2022
Sponsor: Chang Gung Memorial Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Depression
Treatment
N/AClinical Study ID
NCT05620511
201902151A3
Ages > 55 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age > 55 years.
- Major depressive disorder (MDD).
Exclusion
Exclusion Criteria:
- Inability to provide informed consent.
- Dementia, as defined by MMSE < 24 (<17 if illiterate or no education) and clinicalevidence of dementia based on DSM-5 criteria.
- Lifetime diagnosis of bipolar I or II disorder, schizophrenia, schizoaffectivedisorder, schizophreniform disorder, delusional disorder, or current psychoticsymptoms.
- Abuse of or dependence on alcohol or other substances within the past 3 months, andconfirmed by study physician interview.
- High risk for suicide (e.g., active suicide ideation and/or current/recent intent orplan) AND unable to be managed safely in the clinical trial (e.g., unwilling to behospitalized). Urgent psychiatric referral will be made in these cases.
- Non-correctable clinically significant sensory impairment (i.e., cannot hear wellenough to cooperate with interview).
- Unstable medical illness, including delirium, uncontrolled diabetes mellitus,hypertension, hyperlipidemia, or cerebrovascular or cardiovascular risk factors thatare not under medical management.
- Currently under psychotherapy or taking regular meditation or yoga practice (or hadexperience in these activities)
Study Design
Total Participants: 180
Study Start date:
August 01, 2020
Estimated Completion Date:
July 31, 2023
Study Description
Connect with a study center
Che-min Lin
Keelung, 204
TaiwanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.